Table 1.
Characteristics of Eligible Studies
| Author | Year | Country | Study design | Case number | Follow-up period (years) | FTC death | Quality score | ||
|---|---|---|---|---|---|---|---|---|---|
| Death | All | 5 years | 10 years | ||||||
| Lin, JD | 1999 | China | retrospective analysis | 25 | 69 | 7 (0–18) | 47.70% | — | 7 |
| Chow, SM | 2002 | China | retrospective analysis | 37 | 215 | 10.8 (0–20) | 31.20% | — | 9 |
| Passler, C | 2004 | Austria | retrospective analysis | 51 | 168 | 10.8 (0–20) | 30.50% | 21.00% | 8 |
| Lo, CY | 2005 | China | retrospective analysis | 17 | 156 | 14.4 (0.1–38.6) | 6.00% | 12.00% | 8 |
| Pulcrano, M | 2007 | France | retrospective analysis | 12 | 40 | 3.9 (0–19.7) | 30.00% (2.9years)a | — | 6 |
| Asari, R | 2009 | Austria | retrospective analysis | 45 | 207 | 9.7 (1–34) | 18.80% | 22.50% | 9 |
| de Melo TG | 2014 | Brazil | retrospective analysis | 12 | 89 | 9.4 (1–36.6) | 13.48% | — | 7 |
| Kim, HJ | 2014 | Korea | retrospective analysis | 16 | 204 | 3.7 (2.3–8.8) | 6.00% | 15.00% | 9 |
| Stenson, G | 2016 | Sweden | retrospective analysis | 5 | 58 | 11.7 (1.8–25.7) | 3.50% | 34.50% | 7 |
| Lee, YM | 2016 | Korea | retrospective analysis | 4 | 166 | 8.6 (1.1–20.3) | 4.20% | — | 8 |
| HUANG Ji-yuan | 2016 | China | retrospective analysis | 3 | 21 | 0.25–10 | — | 24.60% | 6 |
| Su, DH | 2018 | China | retrospective analysis | 30 | 204 | 8.3 (1–24.4) | 10.60% | 16.50% | 9 |
| Yamazaki, Haruhiko | 2020 | Japan | retrospective analysis | 10 | 478 | 7.7 | — | 2.55% | 9 |
aEnd point of follow-up